Tebolan special 80mg
Dosage with indication of single and daily doses :
Mode and duration of application :
Composition :
One film-coated tablet contains :
Dry extract from Ginkgo biloba leaves (35 - 67:1) 80 mg.
The extract is standardized to 17.6 - 21.6 mg flavone
glycosides, 4.0 - 5.6 mg terpene lactones, of which 2.24 - 2.72 mg ginkgolides
A,B,C and 2.08 - 2.56 mg bilobalide and contains less than 0.4 mg ginkgolic
acids for each film-coated tablet .
Indications :
For the symptomatic treatment of disturbances in cerebral
performance due to organic brain syndrome within the framework of a general
therapeutic concept for demential syndromes (decrease or loss in acquired mental
abilities) having as major symptoms :
Deficient memory, disturbances of concentration, depressive
mood, dizziness, tinnitus and headache.
Note :
Prior to starting treatment with Ginkgo extract,
clarification should be obtained as to whether the pathological symptoms
encountered are not based on an underlying disease requiring a specific
treatment .
Improvement of the pain-free walking distance in peripheral
arterial occlusive disease in FONTAINE stage II (intermittent claudication)
within the framework of physical therapeutical measures, in particular walking
training .
Vertigo, tinnitus of vascular and involutional origin
(dizziness, tinnitus as a result of circulatory disorders or age-related
regressive phenomena) .
Contraindications :
Hypersensitivity to Ginkgo biloba extracts.
Note :
As there are no sufficient examinations available
concerning the application of this preparation in children, it should not be
used in children under 12 years of age .
Since Ginkgo extracts have not yet been sufficiently
investigated in case of depressive mood and headache not related to demential
syndromes, Tebolan special 80 mg may only be used for these symptoms when taking
into consideration and applying all necessary precautions .
Adverse reactions :
In very rare cases, slight gastrointestinal disturbances,
headache or allergic skin reactions have been observed after administration of
Tebolan special 80 mg.
Drug interactions :
It cannot be assessed whether the case of a spontaneous
hyphema after combined intake of a Ginkgo-biloba-containing pharmaceutical and
aspirin is caused by an interaction of these two pharmaceuticals. In a
placebo-controlled double-blind study in subjects, interactions of EGb 761Ò
(daily dose 240 mg) with acetyl salicylic acid (daily dose 500 mg) could not be
demonstrated .
Dosage with
indication of single and daily doses :
Demential syndrome :
1 film-coated tablets (corresponding
to 80 mg Ginkgo extract) to be taken 2-3 times per day .
Peripheral arterial occlusive disease,
vertgo, tinnitus :
1 film-coated tablet (corresponding
to 80 mg Ginkgo extract) to be taken 2 times per day .
Mode and
duration of application :
Mode of administration :
Film-coated tablets are to be taken
unchewed with some liquid. The intake is independent of meals .
Duration of
administration :
- Demential syndrome
:
The duration of the
treatment depends on the severity of symptoms and should last for at least 8
weeks in this chronic disease .
- Peripheral
arterial occlusive disease . Vertigo, tinnitus :
Duration of the
treatment should last for at least 6 to 8 weeks.